Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dimenhydrinate manufacturers

19 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

19 products found

dimenhydrinate

Vials, injection 50 mg/ml - 5 ml, 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

dimenhydrinate

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18130

Manufacturer usually replies in 4 days

dimenhydrinate

Vials 50 mg/ml - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

dimenhydrinate

Injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20847

Manufacturer usually replies in 6 days

dimenhydrinate

Syrup 8 mg, 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20412

Manufacturer usually replies in 7 days

dimenhydrinate

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dimenhydrinate

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

dimenhydrinate

Ampoules, injection 250mg/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18331

Manufacturer usually replies in 10 days

dimenhydrinate

Injection 50 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

dimenhydrinate

Suppositories 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

dimenhydrinate

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17808

Manufacturer usually replies in 14 days

dimenhydrinate

Suppositories 25 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #28571

Manufacturer usually replies in nan days

cinnarizine + dimenhydrinate

Tablets 20 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
United Kingdom, FDA
Manufacturer #2612

Manufacturer usually replies in 4 days

cinnarizine + dimenhydrinate

Tablets 20 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20162

Manufacturer usually replies in 3 days

cinnarizine + dimenhydrinate

Tablets 20 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

cinnarizine + dimenhydrinate

Tablets 20 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18259

Manufacturer usually replies in 5 days

cinnarizine + dimenhydrinate

Tablets 20 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

cinnarizine + dimenhydrinate

Tablets 25 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18649

cinnarizine + dimenhydrinate

Tablets 20 mg + 40 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #1356
Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection. Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.